SMTL ID : 4wev.1

Crystal structure of human AKR1B10 complexed with NADP+ and sulindac

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.45 Å

Oligo State

monomer

Ligands

1 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.1: 31 residues within 4Å: Chain A: G.19, T.20, W.21, D.44, Y.49, K.78, H.111, W.112, S.160, N.161, Q.184, Y.210, S.211, P.212, L.213, G.214, S.215, P.216, D.217, L.229, A.246, I.261, P.262, K.263, S.264, V.265, T.266, R.269, E.272, N.273 Ligands: SUZ.2 24 PLIP interactions: 24 interactions with chain A Hydrogen bonds: A:T.20, A:W.21, A:D.44, A:S.160, A:N.161, A:Q.184, A:S.211, A:L.213, A:G.214, A:S.215, A:S.215, A:D.217, A:S.264, A:V.265, A:T.266, A:E.272, A:N.273 Water bridges: A:D.217, A:R.269, A:R.269, A:R.269 Salt bridges: A:R.269 pi-Stacking: A:Y.210 pi-Cation interactions: A:R.269

1 x SUZ: [(1Z)-5-fluoro-2-methyl-1-{4-[methylsulfinyl]benzylidene}-1H-inden-3-yl]acetic acid(Non-covalent)

SUZ.2: 12 residues within 4Å: Chain A: W.21, V.48, Y.49, H.111, F.123, R.125, G.129, W.220, C.299, L.301, Q.303 Ligands: NAP.1 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:W.21, A:W.21, A:W.21, A:V.48, A:Y.49, A:F.123, A:F.123, A:W.220, A:L.301 Hydrogen bonds: A:Y.49 Salt bridges: A:K.78, A:H.111 Halogen bonds: A:V.48

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cousido-Siah, A. et al., Structural analysis of sulindac as an inhibitor of aldose reductase and AKR1B10. Chem.Biol.Interact. (2015)

Release Date

2015-01-14

Peptides

Aldo-keto reductase family 1 member B10: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
X

Aldo-keto reductase family 1 member B10

Related Entries With Identical Sequence